Substance P plasma concentration during the LH preovulatory surge of the menstrual cycle in the human

Neuroendocrinology Letters

Volumn 27, Issue 3, 2006, Pages 359-364

  Kerdelhué, Bernard ^a,b   Lenoir, Véronique ^b   Scholler, Robert ^b   Jones, Howard W ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b INSERM   (France)

Author keywords

17 estradiol; Human; LH surge; Menstrual cycle; Progesterone; Substance P

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; SUBSTANCE P; SUBSTANCE P ANTAGONIST;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MENSTRUAL CYCLE; OVARY CYCLE; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL;

EID: 33748755364     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Akesson TR. Gonadal steroids regulate immunoreactive tachykinin in the ventromedial nucleus of the rat hypothalamus. J Comp Neurol 1994; 341:351-356.
2. Brown ER, Harlan RE, Krause JE. Gonadal Steroid Regulation of Substance P (SP) and SP-Encoding Messenger Ribonucleic Acids in the Rat Anterior Pituitary and Hypothalamus. Endocrinology 1990; 126:330-340.
3. Chang MM, Leeman SE, Nial HD. Amino acid sequence of substance P. Nature (New Biol) 1971; 232:86-87.
4. Cheeta S, Tucci S, Sandhu J, Williams AR, Rupniak NM, File SE. Anxiolytic actions of the substance P(NK1) receptor antagonist L-760735 and the 5-HT 1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res 2001; 915:170-175.
5. Cheramy A, Michelot R, Leviel V, Nioullon A, Glowinski J, Kerdelhué B. Effect of immunoneutralization of Substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons. Brain Res 1978; 155:404-408.
6. Conover WJ. - Practical Nonparametric Statistics, 3th ed., J. Wiley & Sons, New York (1999), 584 pp.
7. Cuello AC, Kanazawa L. The distribution of substance P immunoreactive fibers in the rat central nervous system. J Comp Neurol 1978; 178:129-156.
8. DePalatis LR Khorram O, McCann SM. Age-, Sex-, and Gonadal Steroid-Related Changes in Immunoreactive Substance P in the Rat Anterior Pituitary Gland. Endocrinology 1985; 117:1368-1373.
9. Dudas B, Merchenthaler I. Close juxtapositions between LHRH immunoreactive neurons and substance P immunoreactive axons in the human diencephalon. J Clin Endocrinol Metab 2002; 87:2946-2953.
10. Duval P, Lenoir V, Moussaoui S, Garret C, Kerdelhué B. Substance P and Neurokinin A variations throughout the rat estrous cycle; comparison with ovariectomized and male rats: I - Plasma, hypothalamus, anterior and posterior pituitary. J Neurosci Res 1996; 45:598-609.
11. Ebner K, Rupniak NM, Sara A, Singewald N. Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats. PNAS 2004; 101:4280-4285.
12. Faria M, Navarra P, Tsagarakis S, Besser GM, Grossman AB. Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro. Brain Res 1991; 538:76-78.
13. Gautreau A, Duval P, Kerdelhué B. Variations in levels of Substance P-encoding -α-β, PreProTachykinin A and Substance P Receptor NK-1 transcripts in the Rat Hypothalamus throughout the Estrous Cycle: A Correlation between amounts of β PreProTachykinin and NK-1 mRNA. Mol Brain Res 1997; 49:157-164.
14. Hershey AD, Dykema PE, Krause JE. Organization, structure, and expression of the gene encoding the rat substance P receptor. J Biol Chem 1991; 266:4366-4374.
15. Hershey AD, Krause JE. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 1990; 247:958-962.
16. Hökfelt T, Kellerth JO, Nilsson G, Pernov B. Substance P localisation in the central nervous system and in some primary sensory neurons. Science 1975; 190:889-890.
17. Jakubowska-Naziemblo B, Antnowicz U, Cannon D, Powell D, Rohde W. Immunoreactive substance P and LH-RH content in median eminence and pituitary gland during proestrus, oestrus, lactation and after anterior hypothalamic deafferentation. Exp Clin Endocrinol 1985; 85:155-166.
18. Kalra SP. Mandatory Neuropeptide-Steroid Signaling for the Preovulatory Luteinizing Hormone-Releasing Hormone Discharge. Endocrine Reviews 1993; 14:507-538.
19. Kerdelhué B, Jones GS, Gordon K, Seltman H, Lenoir V, Millar RP, Williams RF, Hodgen GD. Hypothalamo-Anterior Pituitary Gonadotropin-Releasing Hormone and Substance P systems during the 17 β-estradiol-induced plasma luteinizing hormone surge in the ovariectomized female monkey. Endocrinology 1993; 132:1151-1157.
20. Kerdelhué B, Jones GS, Gordon K, Seltman H, Lenoir V, Williams RF, Hodgen GD. Effects of Substance P and progesterone on the pituitary during the estradiol-induced LH surge in primates. Neuroendocr (Life Sci. Adv.) 1992; 11:81-90.
21. Kerdelhué B, Jones GS, Gordon K, Seltman H, Lenoir V, Williams RF, Hodgen GD. The interaction between hypothalamic GnRH, β-endorphin and Substance P neuronal systems as key regulators of the LH surge: an hypothesis. Neuroendocr (Life Sci Adv) 1992; 11:91-100.
22. Kerdelhué B, Khar A, De Nay D, Langlois Y, Benardo T, Liwska J, Jutisz M. Inhibition in vitro par la Substance P de l'excrétion des gonadotropines induite par le LH-RH á partir de cellules adénohypophysaires de rat en culture. CR Acad Sc Série D 1978; 287:879-882.
23. Kerdelhué B, Tartar A, Lenoir V, El Abed A, Hublau P, Millar RP. Binding studies of Substance P anterior pituitary binding sites: changes in Substance P binding sites during the rat estrous cycle. Regulatory peptides 1985; 10:133-143.
24. Kerdelhué B, Lenoir V, Scholler R, Jones H Jr. ACTH-Cortisol Activity during the 17 β Estradiol and LH preovulatory surges of the menstrual cycle in the Human. Neuroendocrinol Lett 2006; 27(1-2):114-120.
25. Kerdelhué B, Williams RF, Lenoir V, Fardin V, Kolm P, Hodgen GD, Jones GS, Scholler R, Jones HW Jr. Variations in Plasma levels of Substance P and effects of a specific Substance P Antagonist of the NK1 Receptor on Preovulatory LH and FSH Surges and progesterone secretion in the Cycling Cynomolgus Monkey. Neuroendocrinology 2000; 71:228-336.
26. Kiyama H, Maeno H, Tohyama M. Substance P receptor (NK-1) in the central nervous system: possible functions from a morphological aspect. Regul Pept 1993; 46:114-23.
27. Knobil E: The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 1980; 36:53-88.
28. Larsen PJ, Mikkelsen JD, Saermark T. Binding of a iodinated Substance P Analog to a NK-1 Receptor on Isolated Cell Membranes from Rat Anterior Pituitary. Endocrinology 1989; 124:2548-2557.
29. Larsen PJ, Saermark T, Mau SE. Binding of an Iodinated Substance P Analogue to Cultured Anterior Pituitary Prolactin- and Luteinizing Hormone-containing Cells. J Histochem Cytochem 1992; 40:487-493.
30. Makara GB, Kakucska I, Lenoir V, Kerdelhué B, Palkovits M. A substance P-containing hypothalamic neuronal system projects to the median eminence. Brain Res 1986; 374:399-401.
31. Parnet P, Lenoir V, Palkovits M, B. Kerdelhué B. Estrous cycle variations in gonadotropin-releasing hormone, Substance P and P-Endorphin contents in the median eminence, the arcuate nucleus and the medial preoptic nucleus in the rat. A detailed analysis of proestrus changes. J Neuroendocrinol 1990; 2:291-296.
32. Pernow B. Studies on substance P purification, occurrence, and biological actions. Acta Physiol Scand 1953; 29:1-90.
33. Petraglia F, Sutton S, Vale W, Plotsky P. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 1987; 120:1083-1088.
34. Priest CA, Vink KL, Micevych PE. Temporal regulation by estrogen of β-preprotachykinin mRNA expression in the rat ventromedial nucleus of the Hypothalamus. Molecular Brain Research 1995; 28:61-71.
35. Ronnekleiv OK, Kelly MJ, Eskay RL. Distribution of Immunoreactive Substance P Neurons in the Hypothalamus and Pituitary of the Rhesus Monkey. J of Comp Neurol 1985; 224:51-59.
36. Searle SR. - Linear Models, J. Wiley & Sons, New York (1971), 532 1010.
37. Takahashi T, Konishi S, Powell D, Leeman SE, Otsuka M. Identification of the motoneuron-depolarizing peptide in bovine dorsal root as hypothalamic substance P. Brain Res 1974; 73:59-69.
38. Takahashi T, Otsuka M. Regional distribution of substance P in the spinal cord and nerve roots of the cat and the effect of dorsal root section. Brain Res 1975; 87:1-11.
39. Von Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts, J Physiol (Iond) 1931; 72:74-87.
40. Walczewska A, Szkudlarek U, Jakubowska-Naziemblo B, Dziedzic B, Traczyk WZ. Increase of gonadotropin-releasing hormone concentration in pituitary portal blood after substance P administration in male rats. Neuroendocrinology 1998; 67:219-227.
41. Winkler A, Papsdorf G, Odarjuk J, Seims WE, Fickel J, Melzig MF. Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. Eur J Pharmacol 1995; 291:51-55.
42. Wormald PJ, Millar RP, Kerdelhué B. Substance P receptors in human pituitary: a potential inhibitor of luteinizing hormone secretion. J Clin Endocrinol Metab 1989; 69:612-615.
43. Zar JH. Biostatistical Analysis, 4th ed., Prentice-Hall, New Jersey (1999), 663 pp.